Opthea Limited Sponsored ADR (OPT) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Opthea Limited, a biopharmaceutical company focused on innovative treatments for retinal diseases, will engage with investors at the Citi 2024 Global Healthcare Conference. CEO Fred Guerard will lead discussions on Opthea’s advancements, highlighting their Phase 3 trials aimed at enhancing treatment efficacy for conditions like wet age-related macular degeneration.
For further insights into OPT stock, check out TipRanks’ Stock Analysis page.
